Published in Br J Pharmacol on April 01, 2012
Rapamycin extends murine lifespan but has limited effects on aging. J Clin Invest (2013) 2.23
The SIRT1 activator SRT1720 extends lifespan and improves health of mice fed a standard diet. Cell Rep (2014) 1.42
Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin. Prog Neurobiol (2012) 1.13
Rapamycin-induced metabolic defects are reversible in both lean and obese mice. Aging (Albany NY) (2014) 1.12
Mammalian target of rapamycin signaling in diabetic cardiovascular disease. Cardiovasc Diabetol (2012) 1.04
TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists. Cell Death Dis (2013) 1.04
Resveratrol potentiates rapamycin to prevent hyperinsulinemia and obesity in male mice on high fat diet. Cell Death Dis (2013) 1.02
Oxidant stress and signal transduction in the nervous system with the PI 3-K, Akt, and mTOR cascade. Int J Mol Sci (2012) 0.94
Koschei the immortal and anti-aging drugs. Cell Death Dis (2014) 0.93
Regulation of cardiac expression of the diabetic marker microRNA miR-29. PLoS One (2014) 0.92
PRAS40 is an integral regulatory component of erythropoietin mTOR signaling and cytoprotection. PLoS One (2012) 0.92
Sympathetic nervous system catecholamines and neuropeptide Y neurotransmitters are upregulated in human NAFLD and modulate the fibrogenic function of hepatic stellate cells. PLoS One (2013) 0.91
Intermittent Administration of Rapamycin Extends the Life Span of Female C57BL/6J Mice. J Gerontol A Biol Sci Med Sci (2016) 0.90
SIRT1-metabolite binding histone macroH2A1.1 protects hepatocytes against lipid accumulation. Aging (Albany NY) (2014) 0.90
A Critical Kinase Cascade in Neurological Disorders: PI 3-K, Akt, and mTOR. Future Neurol (2012) 0.90
Changing the energy of an immune response. Am J Clin Exp Immunol (2013) 0.88
Wnt1 inducible signaling pathway protein 1 (WISP1) targets PRAS40 to govern β-amyloid apoptotic injury of microglia. Curr Neurovasc Res (2012) 0.88
Comparison of rapamycin schedules in mice on high-fat diet. Cell Cycle (2014) 0.87
Novel directions for diabetes mellitus drug discovery. Expert Opin Drug Discov (2012) 0.86
FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus. Curr Neurovasc Res (2015) 0.85
Non-alcoholic fatty pancreas disease pathogenesis: a role for developmental programming and altered circadian rhythms. PLoS One (2014) 0.84
Rapamycin Modulates Markers of Mitochondrial Biogenesis and Fatty Acid Oxidation in the Adipose Tissue of db/db Mice. J Biochem Pharmacol Res (2013) 0.84
Potential therapeutic effects of mTOR inhibition in atherosclerosis. Br J Clin Pharmacol (2015) 0.84
Rapatar, a nanoformulation of rapamycin, decreases chemically-induced benign prostate hyperplasia in rats. Oncotarget (2015) 0.83
Chronic rapamycin treatment causes diabetes in male mice. Am J Physiol Regul Integr Comp Physiol (2014) 0.83
Amphiregulin activates human hepatic stellate cells and is upregulated in non alcoholic steatohepatitis. Sci Rep (2015) 0.83
Rapamycin Increases Mortality in db/db Mice, a Mouse Model of Type 2 Diabetes. J Gerontol A Biol Sci Med Sci (2015) 0.82
An emerging role for the Mammalian target of rapamycin in "pathological" protein translation: relevance to cocaine addiction. Front Pharmacol (2012) 0.82
Single rapamycin administration induces prolonged downward shift in defended body weight in rats. PLoS One (2014) 0.81
The two faces of miR-29. J Cardiovasc Med (Hagerstown) (2015) 0.81
Severe everolimus-induced steatohepatis: a case report. Eur J Med Res (2013) 0.80
Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR. Neural Regen Res (2016) 0.80
Erythropoietin and diabetes mellitus. World J Diabetes (2015) 0.80
Reversal of muscle atrophy by Zhimu-Huangbai herb-pair via Akt/mTOR/FoxO3 signal pathway in streptozotocin-induced diabetic mice. PLoS One (2014) 0.80
10-Hydroxy-2-decenoic Acid, the Major Lipid Component of Royal Jelly, Extends the Lifespan of Caenorhabditis elegans through Dietary Restriction and Target of Rapamycin Signaling. J Aging Res (2015) 0.79
Impact of caloric restriction on myocardial ischaemia/reperfusion injury and new therapeutic options to mimic its effects. Br J Pharmacol (2014) 0.79
Regulation of cardiac miR-208a, an inducer of obesity, by rapamycin and nebivolol. Obesity (Silver Spring) (2015) 0.78
Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling. J Cachexia Sarcopenia Muscle (2016) 0.78
Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and Perspectives. Front Pharmacol (2016) 0.77
Rapamycin impairs HPD-induced beneficial effects on glucose homeostasis. Br J Pharmacol (2015) 0.75
mTOR Inhibition: Reduced Insulin Secretion and Sensitivity in a Rat Model of Metabolic Syndrome. Transplant Direct (2016) 0.75
Increased Skeletal Muscle GLUT4 Expression in Obese Mice After Voluntary Wheel Running Exercise Is Posttranscriptional. Diabetes (2016) 0.75
Blockade of the acute activation of mTOR complex 1 decreases hypertrophy development in rats with severe aortic valve regurgitation. Springerplus (2015) 0.75
The Molecular Mechanism of Glucagon-Like Peptide-1 Therapy in Alzheimer's Disease, Based on a Mechanistic Target of Rapamycin Pathway. CNS Drugs (2017) 0.75
TOR signaling in growth and metabolism. Cell (2006) 35.29
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell (2006) 18.36
Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab (1965) 14.95
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol (2004) 12.12
mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature (2007) 7.12
Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab (2006) 4.98
Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis. J Cell Biol (2004) 4.70
Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab (2008) 4.36
Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell (2007) 3.82
Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation. Mol Cell Biol (2006) 3.67
mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol Med (2007) 3.66
Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance. Proc Natl Acad Sci U S A (2007) 3.32
Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol Cell Biol (1999) 2.91
mTOR signaling and drug development in cancer. Nat Rev Clin Oncol (2010) 2.77
Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue. Diabetes (2010) 2.65
mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes. Diabetes (2008) 2.64
Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br J Nutr (2003) 2.62
Common corruption of the mTOR signaling network in human tumors. Oncogene (2008) 2.60
Targeting mammalian target of rapamycin (mTOR) for health and diseases. Drug Discov Today (2006) 2.59
Sirolimus is associated with new-onset diabetes in kidney transplant recipients. J Am Soc Nephrol (2008) 2.59
mTOR and the control of whole body metabolism. Curr Opin Cell Biol (2009) 2.52
Insulin action on glucose transporters through molecular switches, tracks and tethers. Biochem J (2008) 2.38
Muscle-specific deletion of rictor impairs insulin-stimulated glucose transport and enhances Basal glycogen synthase activity. Mol Cell Biol (2007) 2.32
Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism. Diabetes (2010) 2.30
IRS1-independent defects define major nodes of insulin resistance. Cell Metab (2008) 2.16
mTOR complex 2 in adipose tissue negatively controls whole-body growth. Proc Natl Acad Sci U S A (2009) 2.05
Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review. Drugs (2007) 1.76
Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients. Diabetes Care (1994) 1.67
Tissue-specific roles of IRS proteins in insulin signaling and glucose transport. Trends Endocrinol Metab (2006) 1.64
Development regulation of the subcellular distribution and glycosylation of GLUT1 and GLUT4 glucose transporters during myogenesis of L6 muscle cells. J Biol Chem (1992) 1.62
Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients. J Lipid Res (2002) 1.56
Sirolimus is associated with reduced islet engraftment and impaired beta-cell function. Diabetes (2006) 1.49
Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus. J Am Soc Nephrol (2005) 1.49
Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes. Hepatology (2009) 1.45
Mammalian target of rapamycin complex 1 suppresses lipolysis, stimulates lipogenesis, and promotes fat storage. Diabetes (2010) 1.44
Management of side effects of sirolimus therapy. Transplantation (2009) 1.43
Long-term administration of rapamycin reduces adiposity, but impairs glucose tolerance in high-fat diet-fed KK/HlJ mice. Basic Clin Pharmacol Toxicol (2009) 1.28
Respiratory chain dysfunction in skeletal muscle does not cause insulin resistance. Biochem Biophys Res Commun (2006) 1.27
PTEN down-regulation by unsaturated fatty acids triggers hepatic steatosis via an NF-kappaBp65/mTOR-dependent mechanism. Gastroenterology (2007) 1.26
Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets. Diabetes (2003) 1.25
The applicability of mTOR inhibition in solid tumors. Curr Cancer Drug Targets (2009) 1.11
Maturation of the regulation of GLUT4 activity by p38 MAPK during L6 cell myogenesis. J Biol Chem (2003) 1.10
The impact of the mTOR inhibitor sirolimus on the proliferation and function of pancreatic islets and ductal cells. Diabetologia (2006) 1.07
Severe hepatic and peripheral insulin resistance as evidenced by euglycemic clamps in genetically obese fa/fa rats. Endocrinology (1986) 1.04
The insulin-dependent biosynthesis of GLUT1 and GLUT3 glucose transporters in L6 muscle cells is mediated by distinct pathways. Roles of p21ras and pp70 S6 kinase. J Biol Chem (1995) 1.03
Tuberous sclerosis complex-1 deficiency attenuates diet-induced hepatic lipid accumulation. PLoS One (2011) 1.00
Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats. Diabetologia (1994) 0.99
HPLC assay with ultraviolet detection for therapeutic drug monitoring of sirolimus. Clin Chem (2001) 0.97
Simultaneous quantification of cyclosporine, tacrolimus, sirolimus and everolimus in whole blood by liquid chromatography-electrospray mass spectrometry. Clin Biochem (2008) 0.97
Focal adhesion kinase (FAK) regulates insulin-stimulated glycogen synthesis in hepatocytes. J Biol Chem (2002) 0.90
The Lou/C rat: a model of spontaneous food restriction associated with improved insulin sensitivity and decreased lipid storage in adipose tissue. Am J Physiol Endocrinol Metab (2009) 0.89
The metabolic impact of rapamycin (sirolimus) in chronic canine islet graft recipients. Transplantation (1996) 0.86
In vivo and in vitro effect of sirolimus on insulin secretion. Transplantation (2007) 0.85
Incidence of posttransplant diabetes mellitus in kidney transplant recipients immunosuppressed with sirolimus in combination with cyclosporine. Transplant Proc (2006) 0.84
Toxicity of rapamycin--a comparative and combination study with cyclosporine at immunotherapeutic dosage in the rat. Transplantation (1991) 0.84
Documenting GLUT4 exocytosis and endocytosis in muscle cell monolayers. Curr Protoc Cell Biol (2010) 0.83
Fibronectin-binding protein acts as Staphylococcus aureus invasin via fibronectin bridging to integrin alpha5beta1. Cell Microbiol (1999) 3.17
Immediate and long-term results of bronchial artery embolization for life-threatening hemoptysis. Chest (1999) 2.95
Nef-induced CD4 degradation: a diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of beta-COP in endosomes. Cell (1999) 2.89
Distinct roles for the yeast phosphatidylinositol 4-kinases, Stt4p and Pik1p, in secretion, cell growth, and organelle membrane dynamics. Mol Biol Cell (2000) 2.87
Mechanism of Nef-induced CD4 endocytosis: Nef connects CD4 with the mu chain of adaptor complexes. EMBO J (1998) 2.25
Lung volume reduction in patients with severe diffuse emphysema. A retrospective study. Chest (1996) 2.06
A prospective survey of nutritional support practices in intensive care unit patients: what is prescribed? What is delivered? Crit Care Med (2001) 2.04
Paradoxical acute brain thromboembolism during prostacyclin (PGI2) acute challenge for primary pulmonary hypertension. Eur Heart J (1996) 2.03
The HIV-1 Nef protein acts as a connector with sorting pathways in the Golgi and at the plasma membrane. Immunity (1997) 1.78
Diaphragm motor unit recruitment during ventilatory and nonventilatory behaviors. J Appl Physiol (1985) (1989) 1.75
Variation of daily warm season mortality as a function of micro-urban heat islands. J Epidemiol Community Health (2009) 1.73
Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema. Thorax (2008) 1.70
Hypothyroidism in rats decreases peripheral glucose utilisation, a defect partially corrected by central leptin infusion. Diabetologia (2005) 1.58
Purification of tRNATrp, tRNAVal, and partial purification of tRNAIle and tRNAMfet from beef liver. Biochimie (1976) 1.58
Human immunodeficiency virus reverse transcriptase expressed in transformed yeast cells. Biochemical properties and interactions with bovine tRNALys. Eur J Biochem (1989) 1.56
Barrett's oesophagus: long-term follow-up after complete ablation with argon plasma coagulation and the factors that determine its recurrence. Aliment Pharmacol Ther (2007) 1.54
Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology (1993) 1.52
Enzymatic conversion of adenosine to inosine and to N1-methylinosine in transfer RNAs: a review. Biochimie (1996) 1.51
Coordinated events during bacteria-induced DC maturation. Immunol Today (1999) 1.47
Architectural, histochemical, and contractile characteristics of a unique biarticular muscle: the cat semitendinosus. J Neurophysiol (1982) 1.45
Immunity to diphtheria and tetanus in a young population on a dialysis regimen or with a renal transplant. J Pediatr (1997) 1.41
[Unilateral choroid metastasis revealing bronchial adenocarcinoma in a woman]. Presse Med (1995) 1.40
Skeletal muscle adaptation in adolescent boys: sprint and endurance training and detraining. Med Sci Sports Exerc (1982) 1.39
Energy expenditure and substrates oxidative patterns, after glucose, fat or mixed load in normal weight subjects. Eur J Clin Nutr (1997) 1.39
Severe tracheobronchial stenosis in a patient with Crohn's disease. Eur Respir J (2000) 1.38
CD14-dependent endotoxin internalization via a macropinocytic pathway. J Biol Chem (1998) 1.33
Role of ventromedial hypothalamus on sympathetic efferents of brown adipose tissue. Am J Physiol (1984) 1.30
Fibroblast growth factor 21 protects against cardiac hypertrophy in mice. Nat Commun (2013) 1.29
Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinoma. Cancer (1982) 1.28
Inhibition of the p66/p51 form of human immunodeficiency virus reverse transcriptase by tRNA(Lys). Nucleic Acids Res (1990) 1.28
Insulin: its relationship to the central nervous system and to the control of food intake and body weight. Am J Clin Nutr (1985) 1.25
Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group. Leukemia (2000) 1.25
Direct effects of leptin on brown and white adipose tissue. J Clin Invest (1997) 1.22
Pathology and toxicology of beluga whales from the St. Lawrence Estuary, Quebec, Canada. Past, present and future. Sci Total Environ (1994) 1.19
Induction of obesity and hyperleptinemia by central glucocorticoid infusion in the rat. Diabetes (1999) 1.18
Central respiratory drive in acute respiratory failure of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis (1980) 1.16
Hepatotoxicity of antitubercular treatments. Rationale for monitoring liver status. Drug Saf (1996) 1.16
Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents. Diabetologia (2005) 1.15
Early events in dendritic cell maturation induced by LPS. Microbes Infect (1999) 1.15
Architectural alterations of rat hind-limb skeletal muscles immobilized at different lengths. Exp Neurol (1982) 1.15
Site-directed in vitro replacement of nucleosides in the anticodon loop of tRNA: application to the study of structural requirements for queuine insertase activity. EMBO J (1983) 1.14
Soleus motor units in chronic spinal transected cats: physiological and morphological alterations. J Neurophysiol (1986) 1.10
Effect of weight loss on muscle fiber type, fiber size, capillarity, and succinate dehydrogenase activity in humans. J Clin Endocrinol Metab (1999) 1.10
Immunotoxicity of heavy metals in relation to Great Lakes. Environ Health Perspect (1995) 1.09
Primary structure of bovine liver tRNATrp. Biochim Biophys Acta (1978) 1.08
Prognosis of patients with advanced idiopathic pulmonary fibrosis requiring mechanical ventilation for acute respiratory failure. Chest (2001) 1.08
tRNATrp (bovine) binding to the reverse transcriptase of avian myeloblastosis virus and function as a heterologous primer. Proc Natl Acad Sci U S A (1977) 1.08
Biomechanical design and long-term stability of trees: morphological and wood traits involved in the balance between weight increase and the gravitropic reaction. J Theor Biol (2008) 1.07
Enzymatic conversion of adenosine to inosine in the wobble position of yeast tRNAAsp: the dependence on the anticodon sequence. Nucleic Acids Res (1984) 1.06
High contrast 40Gbit/s optical modulation in silicon. Opt Express (2011) 1.06
Possible mechanisms of action of environmental contaminants on St. Lawrence beluga whales (Delphinapterus leucas). Environ Health Perspect (1995) 1.05
Role of glucocorticoids in the physiopathology of excessive fat deposition and insulin resistance. Int J Obes Relat Metab Disord (2004) 1.05
Metabolic consequences of hyperinsulinaemia imposed on normal rats on glucose handling by white adipose tissue, muscles and liver. Biochem J (1990) 1.04
Adult Colorado potato beetles, Leptinotarsa decemlineata compensate for nutritional stress on oryzacystatin I-transgenic potato plants by hypertrophic behavior and over-production of insensitive proteases. Arch Insect Biochem Physiol (2000) 1.04
Non-steady-state measurement of glucose turnover in rats by using a one-compartment model. Am J Physiol (1987) 1.04
Effect of nutritional deprivation on diaphragm contractility and muscle fiber size. J Appl Physiol (1985) (1986) 1.04
Solution structure of a highly stable DNA duplex conjugated to a minor groove binder. Nucleic Acids Res (1998) 1.03
Dual role of a dileucine motif in insulin receptor endocytosis. J Biol Chem (1997) 1.03
The weight-reducing effect of an intracerebroventricular bolus injection of leptin in genetically obese fa/fa rats. Reduced sensitivity compared with lean animals. Diabetes (1996) 1.01
Phagocytic activity of marine and freshwater bivalves: in vitro exposure of hemocytes to metals (Ag, Cd, Hg and Zn). Aquat Toxicol (2002) 1.01
Interactions with tRNA(Lys) induce important structural changes in human immunodeficiency virus reverse transcriptase. FEBS Lett (1990) 1.01
Hyperinsulinemia increases the amount of GLUT4 mRNA in white adipose tissue and decreases that of muscles: a clue for increased fat depot and insulin resistance. Endocrinology (1990) 1.01
Priming of HIV replication by tRNA(Lys3): role of reverse transcriptase. Trends Biochem Sci (1994) 1.01
Chronic central leptin infusion enhances insulin-stimulated glucose metabolism and favors the expression of uncoupling proteins. Diabetes (1998) 1.00
Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance. Diabetes (1997) 1.00
The yellow nail syndrome. Light and electron microscopic aspects of the pleura. Arch Pathol Lab Med (1983) 1.00
Post-transcriptional modification of the wobble nucleotide in anticodon-substituted yeast tRNAArgII after microinjection into Xenopus laevis oocytes. Nucleic Acids Res (1983) 1.00
Flow limitation and dynamic hyperinflation during exercise in COPD patients after single lung transplantation. Chest (2000) 0.99
Functional interactions of human immunodeficiency virus type 1 integrase with human and yeast HSP60. J Virol (2001) 0.99
Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia. Diabetologia (1997) 0.99
Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats. Diabetologia (1994) 0.99
The ob gene and insulin. A relationship leading to clues to the understanding of obesity. Diabetes (1995) 0.99
Myosin phenotype and SDH enzyme variability among motor unit fibers. J Appl Physiol (1985) (1996) 0.99
Obesity, leptin, and the brain. N Engl J Med (1996) 0.99
Modulation of cytokine expression in mouse dendritic cell clones. Eur J Immunol (1994) 0.98
The SCOPE study: health-care consumption related to patients with chronic obstructive pulmonary disease in France. Value Health (2004) 0.98
Cellular adaptations of skeletal muscles to cyclosporine. J Appl Physiol (1985) (1998) 0.98
Fiber type composition of muscle units in the cat diaphragm. Neurosci Lett (1989) 0.98
Hyperpolarizing gases via dynamic nuclear polarization and sublimation. Phys Rev Lett (2010) 0.97
Epithelial vs. serosal stimulation of tracheal muscle: role of epithelium. J Appl Physiol (1985) (1989) 0.97
Ecotoxicity of CdTe quantum dots to freshwater mussels: impacts on immune system, oxidative stress and genotoxicity. Aquat Toxicol (2007) 0.96
Preferential channeling of energy fuels toward fat rather than muscle during high free fatty acid availability in rats. Diabetes (2001) 0.96
Intracerebroventricular glucocorticoid infusion in normal rats: induction of parasympathetic-mediated obesity and insulin resistance. Obes Res (2001) 0.95
Flow cytometry as a tool to monitor the disturbance of phagocytosis in the clam Mya arenaria hemocytes following in vitro exposure to heavy metals. Toxicology (2000) 0.95
An arginine to cysteine(252) mutation in insulin receptors from a patient with severe insulin resistance inhibits receptor internalisation but preserves signalling events. Diabetologia (2002) 0.95
Deficiency in the NADPH oxidase 4 predisposes towards diet-induced obesity. Int J Obes (Lond) (2012) 0.95
Early release of proinflammatory cytokines after lung transplantation. Chest (1998) 0.94
Tumor necrosis factor plays an essential role in determining hypersensitivity pneumonitis in a mouse model. Am J Respir Cell Mol Biol (1991) 0.94
Effects of prenatal undernutrition on developing rat diaphragm. J Appl Physiol (1985) (1993) 0.94
Retroviral immortalization of phagocytic and dendritic cell clones as a tool to investigate functional heterogeneity. J Immunol Methods (1994) 0.94
EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium. J Steroid Biochem Mol Biol (1999) 0.94
Adrenalectomy prevents the obesity syndrome produced by chronic central neuropeptide Y infusion in normal rats. Diabetes (1997) 0.94
Immunotoxicity of pesticides: a review. Toxicol Ind Health (1999) 0.93
Desulfurispirillum alkaliphilum gen. nov. sp. nov., a novel obligately anaerobic sulfur- and dissimilatory nitrate-reducing bacterium from a full-scale sulfide-removing bioreactor. Extremophiles (2007) 0.93
Cytotoxic and neoplastic transforming effects of industrial hexavalent chromium pigments in Syrian hamster embryo cells. Carcinogenesis (1989) 0.93
Photochemical cross-linking studies on the interactions of avian myeloblastosis virus reverse transcriptase with primer tRNATrp and TTP. Arch Biochem Biophys (1980) 0.93
Increased apoptosis, changes in intracellular Ca2+, and functional alterations in lymphocytes and macrophages after in vitro exposure to static magnetic field. J Toxicol Environ Health A (1998) 0.93
Four-day hyperinsulinemia in euglycemic conditions alters local cerebral glucose utilization in specific brain nuclei of freely moving rats. Brain Res (1995) 0.92